Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
23.1M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+322K
-
Total reported value, excl. options
-
$35M
-
Value change
-
+$847K
-
Number of buys
-
22
-
Number of sells
-
-8
-
Price
-
$2.62
Significant Holders of Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) as of Q1 2024
39 filings reported holding TSBX - Turnstone Biologics Corp. - Common Stock, par value $0.001 per share as of Q1 2024.
Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 23.1M outstanding shares and own 57.68% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.1M shares), FMR LLC (1.57M shares), Point72 Asset Management, L.P. (1.18M shares), PFM Health Sciences, LP (921K shares), BANK OF AMERICA CORP /DE/ (899K shares), TAKEDA PHARMACEUTICAL CO LTD (896K shares), CITADEL ADVISORS LLC (685K shares), BlackRock Inc. (663K shares), 72 Investment Holdings, LLC (550K shares), and SECTORAL ASSET MANAGEMENT INC (518K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.